Celgene (CELG) PT Lifted to $150 at Cowen Amid Solid Q2
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Celgene Reports Second Quarter 2015 Operating and Financial Results
July 23, 2015 7:30 AM EDTREVLIMID® Net Product Sales $1,444 Million; Increased 19% Y/Y POMALYST®/IMNOVID® Net Product Sales $235 Million; Increased 46% Y/Y ABRAXANE® Net Product Sales $244 Million; Increased 13% Y/Y OTEZLA® Net Product Sales $90 Million
SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ: CELG) reported net product sales of $2,254 million for the second quarter of 2015, a 22 percent increase from the same period in 2014. The negative net impact of currency... More
